Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.16 for the Quarter Ended June 30, 2008
Date:8/6/2008

- Mylan Increases Adjusted EPS Guidance for 2008 to $0.47

- $0.53

PITTSBURGH, Aug. 6 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) today announced its financial results for the three and six months ended June 30, 2008.

Financial Highlights

-- Adjusted diluted EPS of $0.16 for the three months ended June 30, 2008, which excludes the impact of certain purchase accounting items as well as other non-recurring items as discussed in detail below;

-- Total revenues of $1.20 billion for the three months ended June 30, 2008, an increase of $656.8 million over the same prior year period; and

-- On a GAAP basis, primarily as a result of purchase accounting items, the Company reported a loss per diluted share of $0.03 for the three months ended June 30, 2008.

"Our strong second quarter results were driven by a solid performance by each of our operating units and reflect the value we anticipated when we created our global platform," said Mylan Vice Chairman and CEO Robert J. Coury. "Based on the strength of our operations, our integration successes and the momentum of three consecutive quarters of strong results, we have increased the range of our earnings guidance."

Detailed Financial Summary

Mylan previously had two reportable segments, the Mylan Segment and the Matrix Segment. With the acquisition of Merck Generics on October 2, 2007, Mylan now has three reportable segments: Generics Segment (or Generics), Specialty Segment (or Specialty) and the Matrix Segment (or Matrix). The former Mylan Segment is included within the Generics Segment. Additionally, certain general and administrative and research and development expenses not allocated to the segmen
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Mylan Announces Final FDA Approval for Carvedilol Tablets
3. Mylan Announces Tentative FDA Approval for Topiramate Capsules
4. Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
5. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
6. Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
7. Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
8. Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
9. Mylan Announces Appointment of Harry A. Korman as President, North America
10. Mylan Announces Appointment of John Montgomery as President, Asia Pacific
11. Mylan Announces Management of Specialty Business, Dey L.P.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... California (PRWEB) May 19, 2013 According to ... Body Firmers” many people are self-conscious about the appearance of ... an option when diet and exercise fail to tone and ... may appeal to those looking to get the firmest ... is an effective mini-overview,” says Dr. Simon Ourian, Medical Director ...
(Date:5/19/2013)... St. Louis, MO (PRWEB) May 19, 2013 ... Member Conference, May 19-22, 2013, at the Walt Disney ... the latest trends in supply chain innovation, care delivery ... a much different dynamic in all healthcare markets, ... necessary part of the conversation,” said Todd Ebert, Amerinet ...
(Date:5/19/2013)... Omaha, Nebraska is a city of diversity, economic growth ... the lowest unemployment rates in the country. Forbes Magazine distinguished ... Business and Careers and it consistently scores high on many ... in the nation and is a strong business leader thanks ... Editions TV are pleased to announce air dates ...
(Date:5/19/2013)... in Minnesota have a great option to get in shape ... Fat Loss Formula. The best part is people can ... The product sells for $135 dollars and is an immediate ... http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is almost here. People may ... the 28 Day Fat Loss Formula they will be happy ...
(Date:5/19/2013)... 2013 In partnership with the medical practice ... the launch of an SEO website for dentists. The purpose ... in Google. , http://www.e-dentists.com/ , A perk to ... service until they see results. Dentists can request the keywords ... run by JD Media Surge, LLC rank high for competitive ...
Breaking Medicine News(10 mins):Health News:Body Firming – The Hottest Treatments Available 2Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2
... According to a new federal report, in spite of the ... several new programs to overcome it//, the efficacy of these ... efforts need national leadership, according to the report, Progress in ... Institute of Medicine. This report was released yesterday. ...
... revealed that there is a “crisis” over lack of donors at ... clinics being totally out of stock//, women and couples wanting to ... the highest number of donors was 459. Ever since, the number ... law was passed that gave kids the right to know the ...
... week the distribution of a drug to help fight an ... is being affected by an extremely virulent strain of tuberculosis, ... the country. The health officials have now promised that they ... week to help fight the disease. The officials but also ...
... for an extensive study for the evaluation of the possible ... stents. // ,Stents are widely used heart devices ... had essentially eliminated short-term restenosis as a complication of coronary ... cloud for possible late-term risks. Reports indicate that almost 6 ...
... unique way to curb binge drinking, researchers say parents should allow ... youngsters // to drink at parties and at home may be ... ,Professor Mark Bellis, the author of the report said that children ... and allowed to drink with them were sensible in their approach ...
... a safe way to monitor the fate of transplanted ... issue of the journal Diabetes. // Researchers from the ... (MGH) said that they were able to track transplanted ... human transplants. ,"Clinical trials and animal studies ...
Cached Medicine News:Health News:Slow Fight Against Childhood Obesity 2Health News:Slow Fight Against Childhood Obesity 3Health News:Shortage of donors at sperm bank clinics 2Health News:South Africa To Make Available Two New Drugs To Fight The TB Outbreak 2Health News:MRI Can Monitor Transplanted Islets 2
(Date:5/17/2013)... Rico , May 17, 2013  Serving a region ... Puerto Rico , Caribbean Imaging and Radiation Therapy (CIRT, ... radiation therapy capabilities with the acquisition of an Elekta Versa ... . Versa HD offers clinicians the versatility to deliver conventional ... body, while also enabling treatment of highly complex cancers that ...
(Date:5/17/2013)... PARIS , May 17, 2013  Sanofi (EURONEXT: ... the pivotal study, JAKARTA , examining ... its primary endpoint in both dose groups. The primary ... of spleen volume. Consistent with data reported in previous ... nausea and vomiting. Full results will be presented at ...
(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease.  Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million.  The ...
Breaking Medicine Technology:Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
... , NEW YORK , July 20 ... the Susquehanna International Group of Companies (SIG), announced today that ... Senior Analyst covering the Specialty Pharmaceuticals sector. Mr. Nachman, whose ... Labs , King Pharmaceuticals, Shire Pharmaceuticals and Warner Chilcott ...
... July 20 Medical Device Consultants, Inc. ... (CRO) serving the medical device and diagnostics industry, today ... Services Ltd (CDSS), a clinical services and CRO based ... clients access to the best of both organizations, core ...
Cached Medicine Technology:Susquehanna Financial Group Hires Gary Nachman as Senior Analyst to Cover the Specialty Pharmaceuticals Sector 2Susquehanna Financial Group Hires Gary Nachman as Senior Analyst to Cover the Specialty Pharmaceuticals Sector 3Medical Device Consultants, Inc. and Clinical Development & Support Services Ltd Announce Strategic Partnership 2Medical Device Consultants, Inc. and Clinical Development & Support Services Ltd Announce Strategic Partnership 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: